Thankamma Ajithkumar

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Harpreet Singh Wasan · 2 shared papers, 2022–2024 · strength 0.29
   • Paper Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally ad… DOI 10.1016/j.ejca.2024.114236↗
   • Paper Results of a single-arm pilot study of 32P microparticles in unresectable locally advanced pancreatic adenocarcinoma wi… DOI 10.1016/j.esmoop.2021.100356↗
2. Katy Hickman · 1 shared paper, 2022 · strength 0.26
   • Paper Endoscopic ultrasound-guided neurolysis in advanced pancreatic cancer: current status. DOI 10.1136/bmjspcare-2021-002905↗
3. Tim Maughan · 1 shared paper, 2024 · strength 0.16
   • Paper Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally ad… DOI 10.1016/j.ejca.2024.114236↗
4. Christopher Mark Jones · 1 shared paper, 2024 · strength 0.16
   • Paper Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally ad… DOI 10.1016/j.ejca.2024.114236↗
5. D. Holyoake · 1 shared paper, 2024 · strength 0.16
   • Paper Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally ad… DOI 10.1016/j.ejca.2024.114236↗
6. Ganesh Radhakrishna · 1 shared paper, 2024 · strength 0.16
   • Paper Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally ad… DOI 10.1016/j.ejca.2024.114236↗
7. M. Hawkins · 1 shared paper, 2024 · strength 0.16
   • Paper Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally ad… DOI 10.1016/j.ejca.2024.114236↗
8. Somnath Mukherjee · 1 shared paper, 2024 · strength 0.16
   • Paper Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally ad… DOI 10.1016/j.ejca.2024.114236↗
9. Chris N Hurt · 1 shared paper, 2024 · strength 0.16
   • Paper Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally ad… DOI 10.1016/j.ejca.2024.114236↗
10. Pippa G. Corrie · 1 shared paper, 2024 · strength 0.16
    • Paper Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally ad… DOI 10.1016/j.ejca.2024.114236↗
11. Eric E. O’Neill · 1 shared paper, 2024 · strength 0.16
    • Paper Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally ad… DOI 10.1016/j.ejca.2024.114236↗
12. Nam Quoc Nguyen · 1 shared paper, 2022 · strength 0.13
    • Paper Results of a single-arm pilot study of 32P microparticles in unresectable locally advanced pancreatic adenocarcinoma wi… DOI 10.1016/j.esmoop.2021.100356↗
13. Paul J. Ross · 1 shared paper, 2022 · strength 0.13
    • Paper Results of a single-arm pilot study of 32P microparticles in unresectable locally advanced pancreatic adenocarcinoma wi… DOI 10.1016/j.esmoop.2021.100356↗
14. Adnan M. Nagrial · 1 shared paper, 2022 · strength 0.13
    • Paper Results of a single-arm pilot study of 32P microparticles in unresectable locally advanced pancreatic adenocarcinoma wi… DOI 10.1016/j.esmoop.2021.100356↗
15. Alain Hendlisz · 1 shared paper, 2022 · strength 0.13
    • Paper Results of a single-arm pilot study of 32P microparticles in unresectable locally advanced pancreatic adenocarcinoma wi… DOI 10.1016/j.esmoop.2021.100356↗
16. Marion Harris · 1 shared paper, 2022 · strength 0.13
    • Paper Results of a single-arm pilot study of 32P microparticles in unresectable locally advanced pancreatic adenocarcinoma wi… DOI 10.1016/j.esmoop.2021.100356↗
17. Mehrdad Nikfarjam · 1 shared paper, 2022 · strength 0.13
    • Paper Results of a single-arm pilot study of 32P microparticles in unresectable locally advanced pancreatic adenocarcinoma wi… DOI 10.1016/j.esmoop.2021.100356↗
18. Daniel Gerald Croagh · 1 shared paper, 2022 · strength 0.13
    • Paper Results of a single-arm pilot study of 32P microparticles in unresectable locally advanced pancreatic adenocarcinoma wi… DOI 10.1016/j.esmoop.2021.100356↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.